MedTrace Logo

Continuous Regional Analysis Device for Neonate Lung

NCT02962505 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2019-03-21

No results posted yet for this study

Summary

The purpose of the study is to assess whether Electrical Impedance Tomography (EIT) has the potential to optimize the ventilator therapy, validate the effectiveness, efficacy and safety of nursing and medical interventions (endotracheal suctioning, posture changes, surfactant therapy, recruitment manoeuvres, etc.) and for early recognition of complications like pneumothorax and endotracheal tube misplacement. The study design is purely observational.

Conditions

  • Infant Respiratory Distress Syndrome
  • Acute Bronchiolitis
  • Acute Respiratory Distress Syndrome

Sponsors & Collaborators

  • Middlesex University London

    collaborator UNKNOWN

  • University College, London

    collaborator OTHER

  • NICU of Makarios III Hospital-The Ministry of Health for the Republic of Cyprus

    collaborator UNKNOWN

  • Bio-Medical Research Foundation

    collaborator UNKNOWN

  • University of Geneva

    collaborator UNKNOWN

  • Linneuniversitetet

    collaborator UNKNOWN

  • SWISSTOM AG

    collaborator UNKNOWN

  • Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

    collaborator OTHER

  • Studio Fifield

    collaborator UNKNOWN

  • Panaxea

    collaborator OTHER

  • University Hospital Schleswig-Holstein

    lead OTHER

Principal Investigators

  • Inez Frerichs, MD · University Medical Center SH, Kiel , Germany

Eligibility

Max Age
7 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-11-30
Primary Completion
2019-03-03
Completion
2019-03-03

Countries

  • Cyprus
  • Finland
  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02962505 on ClinicalTrials.gov